cd38 inhibitor and 5-amino-1mq synergy nad+ is a key mediator of depletion in the brain of ZIKV-infected mice: iScience Emerging chemical strategies for CD38
Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect CD38 expressing macrophages drive age related NAD+ decline Nature Metabolism The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



